Supra-inguinal Fascia Iliaca Compartment Block on Postoperative Management in Total Hip Arthroplasty by Posterior Approach

University of Liege86 enrolled

Overview

Find the impact of supra-inguinal fascia iliaca compartment block on postoperative pain management after total hip arthroplasty by posterior surgical approach

ASA physical status 1, 2 and 3 patients scheduled to undergo elective surgery of total hip arthroplasty under spinal anesthesia. The investigators would like to study the impact of supra-inguinal fascia iliaca block on postoperative pain management after total hip arthroplasty by posterior surgical approach. The principal investigator perform this block with ultrasound technique. The investigators also want to observe if this loco-regional new approach to fascia iliaca block could have influence on opioid side effects, postoperative nausea and vomiting, length of hospitalisation and first mobilisation side effects.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

DOUBLE

Enrollment

Conditions

Arthropathy of Hip

Interventions

Supra-inguinal fascia iliaca compartment blockPROCEDURE

Ultrasound guided loco-regional technique as described by Desmet et al. Fascia iliaca compartment block with in-plane 40 ml ropivacaine 0,375% injection between the ilio-psoas muscle and the internal oblique muscle. Patients in SFICB group have classical multimodal approach to postoperative analgesia with morphine administration by PCA pump

Multimodal analgesia and PCA morphine pumpDRUG

Patients in placebo group have classical multimodal approach to postoperative analgesia with morphine administration by PCA pump

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Adults patients scheduled to undergo elective surgery of total hip arthroplasty by posterior surgical aboard Exclusion Criteria: * Patient refusal * Allergy to used medications or local infection. * Pregnancy * Obesity with body mass index \> 35 * History of chronic pain or fibromyalgia * Drug (opioids) addiction * Treatment with corticosteroids for more than 6 months * Severe kidney or liver diseases * Mental disorders or serious neurological diseases

Locations (1)

CHU de Liège

Liège, Belgium

Outcomes

Primary Outcomes

Opioid sparing

Difference in cumulated morphine consumption in the first 48 hours after surgery

Time frame: 48 hours after the intervention

Secondary Outcomes

Opioid secondaries effects

incidence of secondary effects related to morphine consumption

Time frame: 48 hours after the intervention

Pain management satisfaction: questionnaire

pain management satisfaction score by IPO (International Pain Outcomes) questionnaire

Time frame: 48 hours after the intervention

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.